Efficacy and safety of apatinib in the treatment of recurrent or metastatic cervical cancer patients
Latest Information Update: 21 Jun 2018
At a glance
- Drugs Rivoceranib (Primary)
- Indications Adenocarcinoma; Cervical cancer; Squamous cell cancer
- Focus Therapeutic Use
Most Recent Events
- 21 Jun 2018 New trial record